E-LIB Suche - Ergebnisse für: Koeberle, A.

1

P068 Polyunsaturated fatty acid excess fuels pro-inflammato..:

Meyer, M ; Grabherr, F ; Schwärzler, J...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i234-i235 , 2023

Link: https://doi.org/10.1093/..

2

A multicentre, phase IIa study of zolbetuximab as a single ..:

Türeci, O. ; Sahin, U. ; Schulze-Bergkamen, H....
Annals of Oncology. 30 (2019) 9 - p. 1487-1495 , 2019

Link: https://doi.org/10.1093/..

3

Docosahexaenoic acid in the treatment of rheumatoid arthrit..:

Dawczynski, C. ; Dittrich, M. ; Neumann, T....
Clinical Nutrition. 37 (2018) 2 - p. 494-504 , 2018

Link: https://doi.org/10.1016/..

4

Canephron N reduced immune cell recruitment in experimental..:

Nausch, B. ; Röhrl, J. ; Koeberle, A....
European Urology Supplements. 16 (2017) 3 - p. e230-e231 , 2017

Link: https://doi.org/10.1016/..

5

262 Canephron® N reduces pain in experimental cystitis and ..:

Nausch, B. ; Koeberle, A. ; Werz, O...
European Urology Supplements. 15 (2016) 3 - p. e262 , 2016

Link: https://doi.org/10.1016/..

6

1322 Cetuximab monotherapy and cetuximab plus capecitabine ..:

Kienle, D. ; Winterhalder, R. ; Koeberle, D....
European Journal of Cancer. 51 (2015) - p. S194-S195 , 2015

Link: https://doi.org/10.1016/..

7

Off-label use of anticancer drugs in eastern Switzerland: a..:

Joerger, M. ; Schaer-Thuer, C. ; Koeberle, D....
European Journal of Clinical Pharmacology. 70 (2014) 6 - p. 719-725 , 2014

Link: https://doi.org/10.1007/..

8

Elucidation of the molecular mechanism and the efficacy in ..:

Schaible, A M ; Filosa, R ; Temml, V...
British Journal of Pharmacology. 171 (2014) 9 - p. 2399-2412 , 2014

Link: https://doi.org/10.1111/..

9

Feasibility and acceptance of electronic monitoring of symp..:

Blum, D. ; Koeberle, D. ; Omlin, A....
Supportive Care in Cancer. 22 (2014) 9 - p. 2425-2434 , 2014

Link: https://doi.org/10.1007/..

10

High capacity for leukotriene biosynthesis in peripheral bl..:

Schaible, A.M. ; Koeberle, A. ; Northoff, H....
Prostaglandins, Leukotrienes and Essential Fatty Acids. 89 (2013) 4 - p. 245-255 , 2013

Link: https://doi.org/10.1016/..

11

Safety and pharmacology of gemcitabine and capecitabine in ..:

Joerger, M. ; Huitema, A. D. R. ; Koeberle, D....
Cancer Chemotherapy and Pharmacology. 73 (2013) 1 - p. 113-124 , 2013

Link: https://doi.org/10.1007/..

12

Recent advances and future challenges in the treatment of h..:

Koeberle, D. ; Samaras, P.
memo - Magazine of European Medical Oncology. 4 (2011) 2 - p. 94-97 , 2011

Link: https://doi.org/10.1007/..

13

Inhibition of microsomal prostaglandin E2 synthase‐1 as a m..:

Siemoneit, U ; Koeberle, A ; Rossi, A...
British Journal of Pharmacology. 162 (2010) 1 - p. 147-162 , 2010

Link: https://doi.org/10.1111/..

14

The 5‐lipoxygenase inhibitor, zileuton, suppresses prostagl..:

Rossi, A ; Pergola, C ; Koeberle, A...
British Journal of Pharmacology. 161 (2010) 3 - p. 555-570 , 2010

Link: https://doi.org/10.1111/..

15

Myrtucommulone, a natural acylphloroglucinol, inhibits micr..:

Koeberle, A ; Pollastro, F ; Northoff, H.
British Journal of Pharmacology. 156 (2009) 6 - p. 952-961 , 2009

Link: https://doi.org/10.1111/..